Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

In Vivo Fluorescence Imaging to target HER2 Receptor

Not Accessible

Your library or personal account may give you access

Abstract

The goal of our study is to develop a non-invasive optical method for monitoring of HER2 receptor in-vivo and HER2-specific delivery of therapeutic agents to individualize treatment of HER2-positive cancers (breast cancer).

© 2008 Optical Society of America

PDF Article
More Like This
Detection of Specific Binding to HER2 Receptors by in vivo Fluorescence Lifetime Imaging

Yasaman Ardeshirpour, Victor Chernomordik, Moinuddin Hassan, Rafal Zielinski, Gary Griffiths, Olga Vasalatiy, Aleksandr V. Smirnov, Jay R. Knutson, Samuel Achilefu, Jacek Capala, and Amir Gandjbakhche
BTu3A.24 Biomedical Optics (BIOMED) 2012

In vivo assessment of HER2 Receptors Expression, Using NIR Fluorescence Imaging with Affibody-DyLight Probe

Victor Chernomordik, Moinuddin Hassan, Yasaman Ardeshirpour, Rafal Zielinski, Jacek Capala, and Amir Gandjbakhche
BM2A.3 Biomedical Optics (BIOMED) 2012

Application of NIR Fluorescence Optical Imaging for Quantification of HER2 Receptors Expression in vivo

Victor Chernomordik, Moinuddin Hassan, Sang Bong Lee, Rafal Zielinski, Jacek Capala, and Amir Gandjbakhche
BTuC3 Biomedical Optics (BIOMED) 2010

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved